Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate cardiovascular parameters using echocardiographic and
pharmacokinetics during a daily dose of BiDil and BiDil Extended Release (XR) compared to a
study drug free day.